558 related articles for article (PubMed ID: 11309491)
1. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
[TBL] [Abstract][Full Text] [Related]
3. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
[TBL] [Abstract][Full Text] [Related]
4. Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity.
Jordan RC; Bradley G; Slingerland J
Am J Pathol; 1998 Feb; 152(2):585-90. PubMed ID: 9466585
[TBL] [Abstract][Full Text] [Related]
5. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
6. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.
Kudo Y; Kitajima S; Ogawa I; Miyauchi M; Takata T
Oral Oncol; 2005 Feb; 41(2):105-16. PubMed ID: 15695111
[TBL] [Abstract][Full Text] [Related]
8. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
[TBL] [Abstract][Full Text] [Related]
9. Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma.
Fukuchi M; Masuda N; Nakajima M; Fukai Y; Miyazaki T; Kato H; Kuwano H
Anticancer Res; 2004; 24(2B):777-83. PubMed ID: 15161026
[TBL] [Abstract][Full Text] [Related]
10. The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.
Yeh KH; Kondo T; Zheng J; Tsvetkov LM; Blair J; Zhang H
Biochem Biophys Res Commun; 2001 Mar; 281(4):884-90. PubMed ID: 11237742
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
[TBL] [Abstract][Full Text] [Related]
13. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).
Zhang YW; Nakayama K; Nakayama K; Morita I
Cancer Res; 2003 Apr; 63(7):1623-30. PubMed ID: 12670914
[TBL] [Abstract][Full Text] [Related]
14. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
Ben-Izhak O; Lahav-Baratz S; Meretyk S; Ben-Eliezer S; Sabo E; Dirnfeld M; Cohen S; Ciechanover A
J Urol; 2003 Jul; 170(1):241-5. PubMed ID: 12796697
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
Zheng XY; Ding W; Xie LP; Chen ZD
Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma.
Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD
Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847
[TBL] [Abstract][Full Text] [Related]
17. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
[TBL] [Abstract][Full Text] [Related]
18. P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase.
Sa G; Stacey DW
Exp Cell Res; 2004 Nov; 300(2):427-39. PubMed ID: 15475007
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
Goto A; Niki T; Moriyama S; Funata N; Moriyama H; Nishimura Y; Tsuchida R; Kato JY; Fukayama M
Pathol Int; 2004 Sep; 54(9):675-81. PubMed ID: 15363035
[TBL] [Abstract][Full Text] [Related]
20. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
Wang S; Raven JF; Koromilas AE
Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
